These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 21108571)
21. [The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection]. Boĭko ÉV; Fokina DV; Reĭtuzov VA; Alekperov SI Voen Med Zh; 2011 Jul; 332(7):30-5. PubMed ID: 21938899 [TBL] [Abstract][Full Text] [Related]
22. Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. Shi G; Chen X; Wang H; Wang S; Guo X; Zhang X J Antibiot (Tokyo); 2012 May; 65(5):229-36. PubMed ID: 22334239 [TBL] [Abstract][Full Text] [Related]
23. Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. Roveta S; Schito AM; Marchese A; Schito GC Int J Antimicrob Agents; 2005 Nov; 26(5):366-72. PubMed ID: 16216467 [TBL] [Abstract][Full Text] [Related]
24. A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice. Samonis G; Anaissie EJ; Rosenbaum B; Bodey GP Infect Immun; 1990 Jun; 58(6):1514-7. PubMed ID: 2187800 [TBL] [Abstract][Full Text] [Related]
26. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans. Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610 [TBL] [Abstract][Full Text] [Related]
27. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty. Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026 [TBL] [Abstract][Full Text] [Related]
28. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Kim SJ; Toma HS Ophthalmology; 2011 Jul; 118(7):1358-63. PubMed ID: 21420176 [TBL] [Abstract][Full Text] [Related]
29. Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis. Ahmad Z; Tyagi S; Minkowski A; Peloquin CA; Grosset JH; Nuermberger EL Am J Respir Crit Care Med; 2013 Jul; 188(1):97-102. PubMed ID: 23593945 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells. Kim SY; Park YH; Lee YC Clin Exp Ophthalmol; 2008 May; 36(4):367-70. PubMed ID: 18700925 [TBL] [Abstract][Full Text] [Related]
31. Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans. Samonis G; Maraki S; Hajiioannou I; Chatzinikolaou I; Rolston KV; Bodey GP; Kontoyiannis DP J Chemother; 2001 Feb; 13(1):66-9. PubMed ID: 11233803 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice. Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model. Szałek E; Karbownik A; Grabowski T; Sobańska K; Wolc A; Grześkowiak E Pharmacol Rep; 2013; 65(5):1383-90. PubMed ID: 24399735 [TBL] [Abstract][Full Text] [Related]
34. A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. Enzweiler KA; Bosso JA; White RL Pharmacotherapy; 2003 Jul; 23(7):925-32. PubMed ID: 12885105 [TBL] [Abstract][Full Text] [Related]
35. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy. Murillo O; Pachón ME; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Gudiol F; Ariza J J Infect; 2009 Mar; 58(3):220-6. PubMed ID: 19217166 [TBL] [Abstract][Full Text] [Related]
36. Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial. Chen Y; Yang H; Lu G; Wu X; Huang W; Wu Y; Lv X; Wu G; Zhang G; Li Q; Sun Y Chemotherapy; 2012; 58(3):249-56. PubMed ID: 22890091 [TBL] [Abstract][Full Text] [Related]
37. Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers. Stein GE; Schooley S Int J Antimicrob Agents; 2004 Aug; 24(2):168-72. PubMed ID: 15288316 [TBL] [Abstract][Full Text] [Related]
38. Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty. Metallidis S; Topsis D; Nikolaidis J; Alexiadou E; Lazaraki G; Grovaris L; Theodoridou A; Nikolaidis P J Chemother; 2007 Dec; 19(6):682-7. PubMed ID: 18230551 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae. Deryke CA; Du X; Nicolau DP J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688 [TBL] [Abstract][Full Text] [Related]
40. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]